Vikramdeo, K. S., Miree, O., Anand, S., Sharma, A., Srivastava, S. K., Singh, S., . . . Singh, A. P. MYB/AKT3 axis is a key driver of ovarian cancer growth, aggressiveness, and chemoresistance. BMC.
Chicago Style (17th ed.) CitationVikramdeo, Kunwar Somesh, Orlandric Miree, Shashi Anand, Amod Sharma, Sanjeev Kumar Srivastava, Seema Singh, Rodney P. Rocconi, and Ajay Pratap Singh. MYB/AKT3 Axis Is a Key Driver of Ovarian Cancer Growth, Aggressiveness, and Chemoresistance. BMC.
MLA (9th ed.) CitationVikramdeo, Kunwar Somesh, et al. MYB/AKT3 Axis Is a Key Driver of Ovarian Cancer Growth, Aggressiveness, and Chemoresistance. BMC.
Warning: These citations may not always be 100% accurate.